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Background: Transcription regulation in pluripotent embryonic stem (ES) cells is a complex process that involves
multitude of regulatory layers, one of which is post-translational modification of histones. Acetylation of specific
lysine residues of histones plays a key role in regulating gene expression.
Results: Here we have investigated the genome-wide occurrence of two histone marks, acetylation of histone
H3K9 and K14 (H3K9ac and H3K14ac), in mouse embryonic stem (mES) cells. Genome-wide H3K9ac and H3K14ac
show very high correlation between each other as well as with other histone marks (such as H3K4me3) suggesting
a coordinated regulation of active histone marks. Moreover, the levels of H3K9ac and H3K14ac directly correlate
with the CpG content of the promoters attesting the importance of sequences underlying the specifically modified
nucleosomes. Our data provide evidence that H3K9ac and H3K14ac are also present over the previously described
bivalent promoters, along with H3K4me3 and H3K27me3. Furthermore, like H3K27ac, H3K9ac and H3K14ac can also
differentiate active enhancers from inactive ones. Although, H3K9ac and H3K14ac, a hallmark of gene activation
exhibit remarkable correlation over active and bivalent promoters as well as distal regulatory elements, a subset of
inactive promoters is selectively enriched for H3K14ac.
Conclusions: Our study suggests that chromatin modifications, such as H3K9ac and H3K14ac, are part of the active
promoter state, are present over bivalent promoters and active enhancers and that the extent of H3K9 and H3K14
acetylation could be driven by cis regulatory elements such as CpG content at promoters. Our study also suggests
that a subset of inactive promoters is selectively and specifically enriched for H3K14ac. This observation suggests
that histone acetyl transferases (HATs) prime inactive genes by H3K14ac for stimuli dependent activation. In
conclusion our study demonstrates a wider role for H3K9ac and H3K14ac in gene regulation than originally
thought.
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Embryonic stem (ES) cells provide an important model
system to study developmental regulation and hold signifi-
cant potential for clinical therapeutics because of their
unique capabilities to self re-new and differentiate into
multiple lineages (reviewed in [1]). The chromatin of
pluripotent ES cells have unique characteristics, including
an open conformation, a hyper-dynamic organization of
chromatin proteins, and less condensed heterochromatin
domains, suggesting the plasticity of the genome in ES
cells (reviewed in [2]).
Different modifications of chromatin are associated with
variable functions. Histone modifications such as tri-
methylation of H3 lysine 4 (H3K4me3) and hyperacetyla-
tion of histone H3 and H4 are known as active marks and
are often associated with ongoing transcription [3,4]. On
the other hand, methylation of H3K9 and H3K27, are
known as repressive marks and are associated with gene
silencing [5]. Promoters of key regulatory genes have
unique chromatin modification signatures, which contain
both an active histone mark, H3K4me3, as well as a re-
pressive histone mark, H3K27me3, also known as bivalent
promoters, and are thought to be poised for gene activa-
tion during differentiation [6-8]. Distal regulatory regions,
such as enhancers, are enriched in H3K4me1 (as com-
pared to H3K4me3), histone acetyl transferase (HAT) co
activators (i.e. p300 or ATAC) and have an open chroma-
tin structure [4,9,10]. Not only promoters, but enhancer
regions were also shown to be poised for gene activation
during differentiation as only active enhancers are marked
by the H3K27ac modification [11,12].
One of the most studied modifications of histones is
acetylation of specific lysine (K) residues, which gener-
ally correlates with gene activation. The level of histone
acetylation is regulated by the activity of both histone
acetyl transferases (HATs) and histone deacetylases
(HDACs), which acetlylate and deacetylate lysine resi-
dues of the N terminal histone tails, respectively. Gen-
etic and biochemical studies suggested that HATs have
rather specific roles in gene activation, while genome-
wide experiments rather suggested that HATs are often
recruited simultaneously, and together are acetylating
multiple lysine residues at a given loci [13,14]. Thus, the
biological function of histone acetylation may be rather
additive than specific. In ES cells, acetylation of H3K9
was shown to predict the pluripotency and reprogram-
ming capacity [15] and its level reduces with ES cell dif-
ferentiation [16]. Recent genome-wide studies shed light
on various histone modifications in mES cells [6], how-
ever, the genome-wide role of histone H3 acetylation in
mES cells is poorly understood. In this study, we have
investigated two histone acetylation marks, H3K9 and
H3K14. Acetylation of H3K9 is mainly performed by
histone acetyl transferases GCN5/PCAF and/or Tip60,whereas acetylation of H3K14 is mediated by GCN5/
PCAF, p300/CBP and/or Myst3 [17-19].
The lack of in-depth studies concerning the role of
H3K14ac was due to the absence of reliable and specific
antibodies. Antibodies against modified histone tails are
central research tools in studying chromatin biology at a
genome-wide level. Thus, we have developed a new spe-
cific ChIP-grade antibody against the H3K14 acetylation
mark. By using the antibody we have developed against
H3K14ac and another published commercial antibody
against H3K9ac, we made genome-wide location analysis
of these two acetylation marks in mouse (m) ES cells,
and compared the presence of two marks over various
genomic regions. Our study suggests that these two
marks are present not only over promoters of actively
transcribed genes, but also on the developmentally regu-
lated bivalent promoters, as well as over active enhan-
cers in mES cells. Moreover, the degree of H3K9 and
H3K14 acetylation correlates with the CpG content of
the promoters and transcription level of the genes.
Finally, we observed differential presence of these two
acetylation marks over a subset of inactive genes, which
is marked by low level of H3K14ac and thus seemed to
be prepared for future activation.
Results
Genome-wide acetylation profiles of H3K9 and H3K14
correlate with each other
To understand the role of histone H3 acetylation at
positions K9 and K14 in mouse ES cells, we have sys-
tematically tested the available antibodies raised against
these modified histone tails. We and others have found
that the anti-H3K9ac antibody from Abcam (ab4441) is
specific for the corresponding modification in various
applications including chromatin immunoprecipitation
(ChIP) [20,21]. However, the anti-H3K14ac antibody
from Upstate (07-353), which was used earlier for
genome-wide localization of H3K14ac [3], was shown to
cross-react with other histone modifications [20] and
was found non-applicable for chromatin immunopreci-
pitation coupled high throughput sequencing (ChIP-seq)
[21]. Our ELISA tests showed that it not only cross-
reacts with with the H4K5acK12ac peptide, it also recog-
nizes the non–acetylated H3K14 peptide (Additional file
1: Figure S1). To overcome this limitation and to study
the real genome-wide distribution of H3K14ac, we raised
a specific mouse monoclonal antibody (mAb) against
this modification and confirmed its specificity in several
different tests (Additional file 2: Figure S2).
To gain insight in the genome-wide acetylation profile
of H3K9 and H3K14 residues, ChIP-seq was performed
using the commercially available antibody against H3K9ac
and the new antibody developed against H3K14ac in
this study. Peaks of local enrichment for H3K9ac and
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normalization to input DNA. Further to validate the
peaks obtained in ChIP-seqs for H3K9ac (using ab4441
antibody) and H3K14ac (using 13HH3-1A5 antibody), we
performed ChIP-qPCR on randomly selected genomic
loci enriched for H3K9ac and H3K14ac. All the selected
peaks of H3K9 and H3K14 acetylation from the ChIP-seq
experiments were validated by ChIP-qPCR (Additional
file 3: Figure S3 and Additional file 4: Table S1.
In order to test whether H3K9ac and H3K14ac modifi-
cations have differential preference over various chroma-
tin regions, we compared their presence over promoters
(2000 bp upstream of transcription start sites (TSSs)),
coding exons, introns and distal intergeneic regions
(Figure 1A), which represent 2.5%, 1.6%, 38.7% and
57.2% of the total genome, respectively [22]. First, peaks
of H3K9ac and H3K14ac local enrichment were deter-
mined after sequence alignment and normalization to
input DNA using MACS [23]. Our analyses show that
H3K9ac and H3K14ac peaks are distributed over all four
genomic regions and the frequency of distribution over
promoters is 13.2% and 12.4%, respectively (Figure 1A).
However, approximately 85% of both the H3K9ac and
H3K14ac marks are observed in distal intergenic and in-
tronic regions with significant enrichments, comparable
to promoters (Additional file 5: Figure S4), suggesting
that these two modifications may have a role at distal
intergeneic and intronic regions. Further to compare
H3K9 and H3K14ac marks, a combined list of binding
sites at transcription start sites (TSSs) was established
containing 15595 TSSs. The comparison of H3K9ac and
H3K14ac over these TSSs shows a Pearson correlation
coefficient of 0.73 (Figure 1B), suggesting that the stud-
ied two H3 acetylation marks are present simultaneously
on promoters (Figure 1C). Moreover, H3K9 and H3K14
acetylations have a characteristic bimodal distribution
around the TSSs, with one peak upstream of the TSS,
another single peak (stronger in the case of H3K14ac)
downstream of the TSS, and depletion of the signal right
on the TSS (Figure 1C). To examine the distribution of
these two histone marks over the gene body, composite
profile of both marks spanning the entire gene body
and extending 5 kb upstream from TSSs and 5 kb
downstream of the 3’ end of the genes for combined list
of binding sites over TSSs (15595) was generated
(Figure 1D). The H3K9ac and H3K14ac distribution pro-
files around TSSs suggest that both marks are predomin-
antly located in regions surrounding the TSSs of genes.
Further to confirm that the co-occupancy of H3K9 and
H3K14 observed is not because of cellular heterogeneity,
we performed sequential ChIP for H3K9ac followed by
H3K14ac (Figure 1E). Sequential ChIP demonstrates that
genomic loci are acetylated simultaneously both at
H3K9 as well H3K14. Thus, our analyses suggest that onthe genome H3K9ac and H3K14ac are mostly present at
distal intergenic and intronic regions, specifically
enriched at promoters when localized in the vicinity of
genes and that the two acetylation marks co-occur at
promoters as well as other locations.
Levels of H3K9 and H3K14 acetylations correlate with the
magnitude of gene expression
Global transcription is a hallmark of pluripotent ES cells
that contributes to plasticity and lineage specification
[24]. Histone modifications are known to act in a com-
binatorial fashion to determine the overall outcome of
the gene expression [3]. To explore the correlative rela-
tionship between various active histone marks detected
at promoters and the transcription of the corresponding
genes in mES cells, we compared the level of various
active histone marks with the transcriptional level of the
genes. Densities of active histone marks (H3K9ac,
H3K14ac, H3K4me3 and H3K27ac), as well as total H3
and RNA polymerase II (Pol II), within a 3000 bp win-
dow flanking the TSSs of the expressed genes (12100)
were collected. All expressed genes [8] were divided into
ten categories ranked on the basis of their expression
level. Presence of various active histone marks was ana-
lyzed over these categories. Analysis of histone H3 occu-
pancy, histone modifications (H3K9ac, H3K14ac,
H3K4me3 and H3K27ac) and Pol II around the TSSs
suggest that depletion of the total histone H3 signal and
enrichment of the active promoter marks (H3K9ac,
H3K14ac, H3K4me3 and H3K27ac) at or around TSSs
correlate with the increase in gene expression levels.
Interestingly, H3K9ac is more spread than the other ana-
lyzed active histone marks around the TSSs (Figure 2).
While Pol II is enriched at or slightly downstream of the
TSSs, on these sites the nucleosomes (H3) are depleted
(Figure 2). This genome-wide observation with various
active histone marks is consistent with the notion that
H3K9ac and H3K4me3 near the TSSs destabilize inter-
action between histones and DNA leading to nucleo-
some eviction [25,26]. Taken together, these results
suggest that level of active histone marks (H3K4me3,
H3K9ac, H3K14ac and H3K27ac) over the active pro-
moter chromatin state correlates with the magnitude of
gene expression.
H3K9 and H3K14 acetylation levels correlate with the CpG
content
Cytosine-phosphate diester-guanine (CpG) islands are
usually found at the 5’ end of the regulatory regions of
genes [27]. CpG islands are GC rich, predominantly non-
methylated and their content correlates with H3K4me3
chromatin modification. To explore the relationship be-
tween the CpG content and the levels of H3K9ac and




Figure 1 Genomic distribution of H3K9ac and H3K14ac in mES cells. (A) Distribution of H3K9ac and H3K14ac peaks over the promoters
(2000 bp upstream of TSS,), coding exons, introns and distal intergenic regions. Many of the H3K9 and H3K14 acetylation peaks are at distal
intergenic regions. (B) Dot plot representation of genome-wide co-localization analysis of the H3K9ac and H3K14ac modifications over the 15595
combined promoter list of H3K9 and H3K14ac suggests a strong correlation between these two modifications at promoters. (C) Average input
normalized profile of 15595 combined promoter list of H3K9 and H3K14ac around the transcription starts sites shows bimodal distribution. (D)
Average input normalized whole gene profiles for H3K9ac and H3K14ac modifications over 15595 combined promoter list of H3K9 and H3K14ac.
(E) Sequential ChIP–qPCR quantification for co-occupancy of H3K9ac (primary ChIP) and H3K14ac (secondary ChIP) at randomly selected H3K9
and H3K14 acetylated loci suggest that these loci are co-marked with H3K9 as well H3K14 acetylation. Enrichment after first ChIP using H3K9ac
followed by re-ChIP with no antibody was used as a control. Primer sequences used in ChIP-qPCR is provided in Additional file 4: Table S1. Error
bars represent the standard deviation for three technical replicates.
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their CpG content. On these CpG islands, which are
sorted on the basis of their increasing CpG content, we
looked for the H3K9ac and H3K14ac profile. We found
that indeed CpG content correlates with the level ofH3K9 and H3K14 acetylation, as acetylation over those
sites increases in parallel with the CpG content (Figure 3).
This in turn suggests that the levels of H3K9 and H3K14
acetylations on the nucleosomes positioning around the
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Figure 2 Level of H3K9 and H3K14 acetylation correlates with magnitude of gene expression. A total of 12000 expressed genes in mES
cells were divided into ten groups based on their expression levels, from the top 10% (blue, group 1) to the lowest 10% (purple, group 10). Mean
tag densities of active histone marks; H3K9ac, H3K14ac, H3K4me3, H3K27ac and Pol II within (-/+) 3 kb are positively correlated with the
transcription level of the genes. On the other hand, total H3 densities in the same regions are negatively correlated with the transcription level.
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the fact that CpG enriched genes are generally housekeep-
ing and are widely expressed [8,29].
H3K9 and H3K14 acetylations occur at active enhancers
Transcription from enhancers resulting in enhancer RNAs
(eRNAs) play important regulatory role in maintenance of
gene expression programs [30-32]. Enhancers are key cis-regulatory elements that can affect gene expression inde-
pendent of their orientation or distance in a cell type spe-
cific manner [9]. Enhancers are marked by the presence of
H3K4me1, DNase I hypersensitivity and histone acetyl
transferases such as p300 [4,9] or the GCN5/PCAF-
containing ATAC complex [10]. The important propor-
tion of H3K9 and H3K14 acetylation sites in distal inter-
genic regions (Figure 1A) motivated us to further analyze
Figure 3 Correlation between the CpG content and the H3K9ac and H3K14ac level. 16026 CpG island sites associated with genes were
sorted in descending order (top to bottom) on the basis of CpG content and the total H3, H3K9ac, H3K14ac and H3K4me3 were examined over
them. CpG content on these sites correlates with the level of H3K9 and H3K14 acetylation as well as with the H3K4me3.
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tions, Pol II and p300 that are indicative of enhancers.
Identification of H3K9ac and H3K14ac peaks in intergenic
regions is described in Materials and Methods. During this
analysis we found a strong correlation between H3K9ac or
H3K14ac intergenic sites with either, H3K4me1, H3K27ac,
the presence of Pol II and p300 suggesting that H3K9ac
and H3K14ac mark also enhancers (Additional file 6:
Figure S5). To confirm the presence of H3K9ac and
H3K14ac over enhancers, we took 25036 putative enhan-
cers reported in mES cells [11] and subjected them to k-
means clustering using seqMiner [33]. Further, H3K27ac
was used to distinguish active and inactive/poised enhan-
cers. Our analyses show that active enhancers are
marked by the strong presence of H3K9ac and H3K14ac
along with H3K27ac and H3K4me1 (Figure 4A and 4B)
and those inactive/poised enhancers are marked by
the presence of H3K4me1 together with relatively weak
levels of H3K14ac (Figure 4A and 4C). Thus, our studysuggests that H3K9ac and H3K14ac mark enhancers
and can further discriminate active enhancers from poised/
inactive enhancers.Bivalent promoters are also marked by H3K9 and K14
acetylation in pluripotent mES cells
Many promoters of developmentally regulated genes in
mES cells are marked by H3K4me3 (active histone
mark) as well as polycomb mediated repressive histone
mark, H3K27me3 [6,7] and are known as bivalent pro-
moters. Recent studies have shown that these bivalent
promoters are also bound by Pol II and are transcribed
at very low level [34]. As these promoters have
H3K4me3 and show a very low level of active transcrip-
tion we looked for the presence of H3K9 and H3K14
acetylation over the bivalent promoters to see if this low
level of transcription would also associated with acetyl-
ation on these promoters.
AB C
Figure 4 (See legend on next page.)
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Figure 4 H3K9ac and H3K14ac mark active enhancers along with H3K27ac. (A) Heatmap of the signal density using k-means clustering
observed on 25036 putative enhancers (-/+ 5 kb) from mES cells for H3K4me1 (mark of putative enhancers), H3K27ac, H3K9ac and H3K14ac. On
the basis of presence or absence of H3K27ac enhancers are categorized as active or poised/inactive. UCSC genome browser track of
representative examples of (B) active enhancer and (C) poised/inactive enhancer. Active enhancers have significant enrichment of H3K9ac and
H3K14ac as compared to poised/inactive enhancers as was observed for H3K27ac.
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acetylations over the bivalent promoters, all the 27095
mouse promoters from UCSC genome browser were
taken [28] and subjected to k-means clustering using
seqMiner [33]. H3K4me3 and H3K27me3 (dual hall-
marks of bivalent promoters) were used to get the bi-
valent loci. Pol II was included in the clustering to
differentiate active and inactive genes. The resulting
heatmap is shown in Figure 5A. In agreement with pre-
vious genome-wide studies, there are three distinct cat-
egories of loci. In respect to the studied acetylation (i)
active loci marked by Pol II, H3K4me3, and devoid of
strong H3K27me3 signals are highly enriched in H3K9ac
and H3K14ac, (ii) bivalent loci, which are marked by
H3K4me3, H3K27me3 and low Pol II signals contain
both H3K9ac and H3K14ac signals, and (iii) inactive loci,
on which either of the above signals is missing. Our ana-
lysis suggests that indeed on bivalent promoters H3K9
and H3K14 acetylations occur together with H3K4 and
H3K27 trimethylations (Figure 5A).
To test the presence of H3K9ac and H3K14ac over bi-
valent promoters, we took a subset of randomly selected
loci and successfully validated them by ChIP-qPCR
(Figure 5B). Further to test if H3K9ac and H3K14ac are
functional at these bivalent loci, a HDAC inhibitor and
followed the level of H3K9ac and H3K14ac over time.
First, Oct4 levels were monitored by Western blot to as-
sess the pluripotent state of the ES cells at various time
points after sodium butyrate treatment. We found that
Oct4 levels are comparable in non-treated and sodium bu-
tyrate treated ES cells at various time points (Additional
file 7: Figure S6), suggesting that the pluripotent state of
the cells did not change during the treatment. Next we
analyzed two selected loci for the presence of H3K9ac and
H3K14ac during the sodium butyrate treatment. We
found that inhibition of HDACs by sodium butyrate leads
to increase in H3K9ac and H3K14ac suggesting that these
marks are indeed functionally deposited and are actively
maintained (Figure 5C). UCSC genome browser tracks of
two representative examples on previously characterized
bivalent promoters [8] harboring the H3K9ac and
H3K14ac over the promoters along with H3K4me3 and
H3K27me3 are shown in Figure 5D and 5E. Thus, our
genome-wide analyses show that H3K9ac and H3K14ac
mark bivalent promoters along with active (H3K4me3)
and repressive (H3K27me3) histone marks over develop-
mentally regulated genes in undifferentiated ES cells.Differential correlation of H3K14ac with repressive
histone marks as compared to H3K9ac
We next analyzed co-localization of the H3K9 and H3K14
acetylation marks with various active and repressive his-
tone modifications. The Pearson correlation coefficient
was calculated for these modifications in a window of 2 kb
upstream and downstream the TSSs of all the mouse
refseq genes (27095). Heatmap of various histone modifi-
cations suggest that active histone marks have high correl-
ation and are grouped together for efficient gene
expression (Figure 6A, blue square). Surprisingly, we
observed higher correlation of H3K14ac with various re-
pressive marks, such as H3K27me3 and H3K9me3, when
compared to H3K9ac (Figure 6A, red square). To further
test the association of H3K14ac with inactive marks,
H3K27me3 and H3K9me3, we took 7924 inactive genes,
which lack Pol II and H3K4me3 (Figure 5A) and calcu-
lated the ratio of H3K14ac/H3K9ac tag density. The ratio
of H3K14ac/H3K9ac is significantly higher over inactive
genes as compared to active genes suggesting that
H3K14ac is specifically and significantly enriched at in-
active genes (Figure 6B). In Figure 6B we used
H3K4me3, Pol II signals distinguish active TSSs from in-
active ones. To further strengthen our observations we
took the 500 weakest (or not expressed) and the 500
highest expressed gene promoters, but this time based
on their expression profiles as calculated from RNA-seq
data (kindly provided by the D. Schübeler), and calcu-
lated the ratio of H3K9 and H3K14 acetylation tag dens-
ities over the least expressed and highly expressed
promoters. This analysis again shows that H3K14ac is
specifically enriched at the weakest (or inactive) promo-
ters as compared to H3K9ac (Additional file 8: Figure
S7). This in turn suggests that H3K14ac, which is gener-
ally considered as a mark of active promoters along with
other acetylation marks, can also mark inactive promo-
ters, although to a lesser extent.
A subset of inactive genes is specifically enriched for
H3K14ac
To understand the functionality of H3K14ac over inactive
promoters, we examined the level of this histone mark
over active and inactive genes in presence of sodium bu-
tyrate, a HDAC inhibitor, and compared it to H3K9ac. In
agreement with our above observations, we found that
active genes exhibited a remarkable increase in H3K9ac




Figure 5 (See legend on next page.)
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Figure 5 H3K9ac and H3K14ac associate with active as well as bivalent promoters. (A) Heatmap of the signal density using k-means
clustering observed on 27095 mouse refseq promoters (-/+5 kb) for H3K9ac and H3K14ac along with H3K4me3 and H3K27me3 (hallmark of
bivalent promoters) and Pol II. The clustering of density map shows three different categories of genes. Active promoters having H3K9ac,
H3K14ac, H3K4me3 and Pol II, bivalent promoters showing H3K4me3 and H3K27me3 along with H3K9ac and H3K14ac, and inactive promoters
lacking all above marks along with Pol II. (B) Presence of H3K9ac and H3K14ac over randomly chosen bivalent loci was validated by ChIP-qPCR.
(C) Increase in the H3K9 and H3K14 acetylation over bivalent promoters (Hhip and Gabra4) following HDAC inhibition by sodium butyrate. The
presence of H3K9ac and H3K14ac over these bivalent loci at the indicated time points after the sodium butyrate treatment was measured by
ChIP-qPCR. ChIP signals for H3K9ac and H3K14ac were normalized to total H3. Primer sequences used in ChIP-qPCR is provided in Additional file
4: Table S1. Error bars represent the standard deviation for three technical replicates. (D and E) UCSC genome browser track of two representative
examples of loci showing H3K9ac and H3K14ac over the bivalent promoters.
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level at inactive genes in presence of sodium butyrate
revealed a slow and selective increase in H3K14ac, while
at these sites H3K9ac did not change (Figure 7C and 7D).
The selective increase in H3K14ac at inactive genes in
presence of sodium butyrate suggests that inactive genes
are subjected to constant H3K14 acetylation and deacety-
lation. This dynamic H3K14ac at inactive genes may poise
them for future activation. To test this hypothesis, we
selected 500 inactive genes having higher H3K14ac as
compared to H3K9ac (Figure 8A) and subjected them to
gene ontology (Figure 8B). Our analysis suggests that in-
active genes, which are having significant H3K14ac over
H3K9ac belong to various pathways that are induced by
various stimuli such as sensory perception, olfaction and
chemosensory perception. Other pathways include recep-
tor activities, which are induced upon ligand binding toA
Figure 6 Differential H3K14ac over inactive promoters as compared t
H3, H3K9ac, H3K14ac, H3K4me3, H3K27ac, H3K27me3 and H3K9me3 aroun
H3K4me3 and H3K27ac clustered separately (blue square) to form an active
have higher co-occurrence with H3K14ac as compared to H3K9ac (red squ
active promoters and inactive promoters. Ratio is significantly higher for in
inactive promoters as compared to H3K9ac.activate the signal transduction and ultimately cellular
responses (Figure 8B). Thus, our data indicate that
H3K14ac is selectively present over a subset of non-
expressed genes and HDACs frequently remove this mark
to keep the genes inactive. The coordinated action of
HATs and HDACs may poise these genes for stimuli
dependent activation.
Discussion
H3K9ac and H3K14ac co-occur with other “active” histone
modifications establishing a chromatin conformation that
is compatible with transcription
Recent genome-wide studies have generated comprehen-
sive chromatin landscapes for various transcription fac-
tors and histone modifications [3,14,35]. In our study, by
using a new specific H3K14ac antibody, we show that
H3K9ac and H3K14ac co-occur with other active histoneB
o H3K9ac. (A) Heatmap representing the correlation between total
d the TSS (-/+ 2 kb). Active promoter marks; H3K14ac, H3K9ac,
promoter chromatin state. Inactive marks (H3K9me3 and H3K27me3)
are) (B) Ratio of H3K14ac/H3K9ac ChIP-seq tag density plotted for
active promoters suggesting that level of H3K14ac is higher over
Figure 7 (See legend on next page.)
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Figure 7 Selective increase in H3K14ac over inactive genes in presence of sodium butyrate. (A, B) Rapid increase in the H3K9 and H3K14
acetylation over active promoters (Hspd1 and B230219D22Rik) caused by HDAC inhibitor. The upper panels show the UCSC genome browser
tracks for the genes analysed. (C, D) Selective increase in H3K14ac over the inactive promoters (4930486L24Rik and Dsc1) as compared to H3K9ac
following the treatment with HDAC inhibitor. The upper panels show the UCSC genome browser track for the genes analysed. The presence of
H3K9ac and H3K14ac over these loci at the indicated time points after the sodium butyrate treatment was measured by ChIP-qPCR. ChIP signals
for H3K9ac and H3K14ac were normalized to total H3. Positions of the primers used for ChIP-qPCR is shown in the UCSC genome browser track
and primer sequences are provided in Additional file 4: Table S1. Error bars represent the standard deviation for three technical replicates.
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Thus, it seems that at these sites all these “active” histone
modifications are deposited by the corresponding activ-
ities sequentially, or at the same time, to act in a coordi-
nated way. A possible mechanistic cross-talk between
H3K4me3 and H3 acetylation could occur in the following
steps: (i) histone lysine methyltransferases (HMT), Set1/
COMPASS associates with the early initiating RNA Pol II
through the PAF1 complex to methylated histone H3K4
around promoters [36]; (ii) various HAT complexes (such
as p300/CBP, NuA3, NuA4) would then recognize this
H3K4me3 indirectly or directly [37] and acetylate the
chromatin; (iii) in parallel or subsequently other HATs,A
B
Figure 8 A subset of inactive promoters having high H3K14ac is pois
500 inactive genes around the transcription starts sites (-/+ 5 kb) shows sp
ontology (using David Bioinformatics, http://david.abcc.ncifcrf.gov/) analysis
are activated in a stimuli dependent manner. The gene ontology term is o
enrichment is on the x axis.such as GCN5/PCAF-containing SAGA and ATAC com-
plexes, may recognize the H3K4me3 by the Tudor domain
of their SGF29 subunit [38,39]. This cross-talk between
the H3K4me3 and H3 acetylation is supported by the
observations indicating that knockdown of WDR5 (sub-
unit of several chromatin modifying complexes includ-
ing HMTs and HATs) or Set1 (catalytic subunit) of
H3K4 methyltransferases complex not only decrease the
H3K4me2/3, but they also decrease the acetylation levels
at given promoters [40-42]. Thus, H3K4me3 seems to
provide a binding platform for HATs, which are specific
for the H3 tails, but may not be specific for the given
lysine residue. This in turn would explain the fact that weed for stimuli dependent activation. (A) Average ChIP-seq profile of
ecific enrichment of H3K14ac as opposed to H3K9ac. (B) Gene
of 500 inactive genes having high H3K14ac suggest that these genes
n the y axis, and the negative log of p value indicating significance of
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as H3K9, H3K14 and H3K27) at the 5’ end of the genes,
which follow the presence of H3K4me3 and the under-
lying CpG islands (see below). This would suggest that
some marks (i.e. H3K9ac and H3K14ac) are establish-
ing more the openness of the chromatin, while others
(i.e. H3K4me3) may serve more as a docking site
[43,44]. Thus, all these marks together may be required
to regulate Pol II transcription initiation positively.
The presence of H3K9ac and H3K14ac at promoters
correlates with their CpG content
Approximately 70% of all the annotated gene promoters
are associated with a CpG islands [27], which have distinct
patterns of chromatin configuration. Interestingly, in mES
cells CXXC finger protein 1 (Cfp1), a component of Setd1
histone methyltransferases complex has a preference for
CpG clusters and can be recruited to artificial promoter-
less CpG clusters that subsequently lead to trimethylation
of H3K4, a CpG island promoter signature [45,46]. The
presence of H3K4me3 might be followed by a cascade of
events and consequent acetylation of different H3 and/or
H4 residues (as discussed above). Acetylation (H3K9 and
H3K14) of the nucleosomes associated with the CpG
islands might be acting as a physical barrier to inhibit the
H3K9me3 of the chromatin [47]. Housekeeping gene pro-
moters have generally high CpG content and are often
protected from DNA methylation and methylation of
H3K9, enabling constitutive expression of the associated
genes. Thus, our findings which show a very good correl-
ation between CpG content of promoter regions and
acetylation of the associated nucleosomes on H3K9 and
H3K14, along with H3K4me3 are in a good agreement
with the model in which all these “active” histone marks
influence the local chromatin structure to simplify the
regulation of gene activity (reviewed in [27]). Our results
also suggest the dependence of histone modifications
such as H3K4me3, H3K9ac and H3K14ac on the DNA
sequences underneath.
H3K9 and H3K14 acetylation label active enhancers
together with H3K27 acetylation
Histone modification profiles have been used for identifying
enhancer elements [4]. Enhancers are characterized by high
H3K4me1/H3K4me3 ratio, open chromatin, low Pol II and
presence of HAT co-activators such as p300 [9] and ATAC
[10]. Interestingly, chromatin modification patterns at
enhancers are much more variable and cell type specific,
than chromatin patterns at promoters that are much more
conserved [9,10]. Our study establishes that H3K9ac and
H3K14ac also mark enhancers. Furthermore, like H3K27ac
[11], these two marks can differentiate between the active
and inactive/poised enhancers (Figure 4). RNA Pol II from
these active enhancers produces bidirectional short (<2 kb)non-coding eRNAs, whose expression level correlate with
the proximal gene activity. [30]. Thus, along with H3K27ac,
H3K9ac and H3K14ac can be used to discriminate the ac-
tive enhancers from the inactive/poised enhancers at global
and gene specific level.
Genome-wide bivalent promoters are also marked by
H3K9 and H3K14 acetylation
Here we also show that bivalent promoters are not only
marked by the H3K4me3 and H3K27me3, but also by
the other active histone marks, such as H3K9ac and
H3K14ac. There are two possibilities for the presence of
H3K9ac and H3K14ac over the bivalent promoters. First,
both acetylation marks may be required in addition to
H3K4me3 for preparing these promoters of developmen-
tal genes for rapid induction at later stages. Second, the
presence of H3K9ac and H3K14ac over bivalent promo-
ters might act as a physical barrier and thereby inhibit-
ing the trimethylation of H3K9, which eventually can
lead to a stable silencing of developmentally regulated
genes [48]. Thus acetylation of H3K9 and H3K14 may
be required as a balancing mechanism to inhibit the per-
manent transcriptional silencing of the developmentally
regulated genes [47]. Our genome-wide study showing
presence of H3K9ac at bivalent promoters is in accord-
ance with earlier studies describing the presence of
H3K9ac, along with the active (H3K4me3) and repres-
sive (H3K27me3) chromatin marks, over bivalent pro-
moters in undifferentiated ES cells [49]. Note however
that Hezroni et al. [50] observed only very low H3K9ac
levels over bivalent gene promoters in ES cells. The dif-
ference observed between H3K9ac enrichment over bi-
valent promoters in our data and that of Hezroni et al.
[50] could be attributed to the fact that our ChIP-seq
data shows an increased depth in the coverage of
H3K9ac sites compared to the one obtained previously.
Indeed, we obtained 23 million reads for our H3K9ac
ChIP seq data versus 14 million reads in the former
study. Higher sequencing depth will result in a more
complete coverage of the identified H3K9ac signals and
also identify smaller peaks. Thus, it is possible that we
detect more peaks that would allow us a more thorough
analysis. Alternatively, differential enrichment of
H3K9ac over bivalent promoters in our study and that
of Hezroni et al. [50] is also possible because of the dif-
ferent antibodies used in the two studies, which can
have distinct specificities.
A subset of inactive promoters are specifically enriched
for H3K14ac
H3K9ac and H3K14ac are associated with active promo-
ters and are considered as hallmarks of active transcrip-
tion. However, we observed that in contrast to H3K9ac,
H3K14ac is selectively and specifically associated with
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a subset of inactive promoters. Presence of H3K14ac
on inactive promoters along with H3K9me3 and
H3K27me3 is in agreement with previous observation
where high throughput characterization of combinatorial
histone marks using proteomic approach shows highest
abundance for H3K14ac peptide with activation and re-
pressive marks [51]. Our data suggest that HATs may bind
transiently to a subset of inactive promoters and acety-
lated H3K14, which is then removed by the transient
binding of HDACs. Inhibition of HDACs leads to substan-
tial increase in H3K14ac of these inactive promoters, sug-
gesting that these promoters are subjected to dynamic
regulation by HATs and HDACs. Transient acetylation
and deacetylation of these promoters may keep these pro-
moters unexpressed but at the same time primed for fu-
ture activation upon receiving the external stimuli. It is
thus possible that the presence of H3K14ac over a subset
of inactive promoters may serve as a landing platform for
further HATs, which have bromodomains, such as GCN5/
PCAF, and propagate the acetylation of the given loci at a
later stage. Thus, presence of H3K14ac and the conse-
quent coordinated action of HATs and HDACs over these
inactive genes might poise them for stimuli dependent fu-
ture activation.Conclusions
In this study, we characterized the H3K9 and H3K14 acet-
ylations over various genomic regions in mES cells. Taken
together our data suggest that genome-wide coordinated
modifications of histone acetylation (i.e. H3K9, H3K14
and H3K27) and methylation (H3K4me3) provide a gen-
eral signature for facilitating gene expression over active
promoters. On the other hand we showed differential en-
richment of H3K14ac over inactive promoters. Further-
more our analyses suggest correlation between acetylation
of nucleosomes over the promoters and the underlying
sequences and demonstrate the presence of H3K9ac and
H3K14ac over enhancers, which can be used in the future
studies to discriminate active enhancers from inactive/
poised ones. In conclusion, our comprehensive study of
H3K9ac and H3K14ac demonstrates a wider role for these
to marks in gene regulation than originally thought.Methods
Cell culture
Wild type embryonic stem cells were derived from blasto-
cysts (3.5 PC) and cultivated on feeder cells (37°C, 5%
CO2) in DMEM (4.5 gm/lit), 15% FCS, leukemia inhibiting
factor, penicillin/streptomycin, L-glutamine, and non-
essential amino acids. At least three passages under feeder
free conditions on 0.1% gelatin were used to exclude
feeders.Antibodies
Mouse monoclonal anti-H3K14ac antibody (13HH3-1A5)
was produced against the peptide “STGGK(ac)APRKC”.
The characterization of the antibody is shown in
Additional file 2: Figure S2. The H3K9ac antibody is from
Abcam -ab4441.Sodium butyrate treatment of mES cells
mES cells were treated with 5 mg/ml sodium butyrate
for 0 min, 5 min, 10 min, 30 min, 1 hr, 2 hr, 4 hr, 8 hr
and 12 hr. Cells were cross linked with 1% formaldehyde
and ChIP was performed as described below. Level of
Oct4 was monitored by Western blot to see the pluripo-
tent state of the ES cells at various time points after so-
dium butyrate treatment (Additional file 7: Figure S6).
Similar level of Oct4 at all time points suggest that the
time points we have used for sodium butyrate treatment
have no effect on pluripotency of the ES cells. Tubulin
was used as a loading control. Anti-Oct4 antibody
(611202) used in the Western blot is from BD labs.Chromatin Immunoprecipitation (ChIP) and sequential
ChIP
All ChIP experiments were carried out on 2X107 cells per
antibody. Cells were cross-linked with 1% formaldehyde,
lyses and syndicated in sonication buffer (10 mM
Tris–HCl pH 7.5, 200 mM NaCl, 1% SDS, 4% NP-40,
1 mM PMSF) to obtain an average chromatin size of 200-
500 bp. Chromatin was pre-cleared using 50 μl of a 50%
protein A sepharose (GE healthcare) slurry for 1 h at 4°C
with gentle inverting. Immunoprecipitation were carried
out in 10 ml of IP buffer (20 mM Tris–HCl pH 8.0,
150 mM NaCl, 2 mM EDTA, 1% Triton-X 100). 15 μl of
ZZZ3 and SPT20 serum antibodies were used. Input chro-
matin was obtained after pre-clearing, by de-cross linking
and purifying input DNA using a Qiaquick column
(Qiagen) according to manufacturer’s instructions. Immu-
noprecipitation were carried out with inverting at 4°C for
14–16 h. The samples were then incubated with 50 μL of
a 50% Protein A sepharose slurry for 3 h at 4°C with gen-
tle inverting. IP samples were reverse-cross linked and the
DNA was purified using a Qiaquick column (Qiagen).
Q-PCR using SYBR green was used to validate known tar-
get sites before and after sequencing. For sequential ChIP,
at least four ChIP assays of 2X107 cells were used for the
first IP (H3K9ac). Following standard washing, elution
was performed with 10 mM DTT (30 min, 37°C). The
eluates from four ChIPs were combined, diluted at least
30 times with ChIP dilution buffer and secondary anti-
body (H3K14ac) was incubated overnight. The subsequent
steps were performed as for regular ChIPs. Validation
of ChIP-seq was performed by the assessment of the indi-
vidual enrichment over the control genomic region by
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regions using SYBR Green master mix (Roche).
Chromatin Immunoprecipitation – High throughput-
sequencing (ChIP-seq)
Library preparation and sequencing
We followed the manufacturer's (Solexa) protocol for
creating genomic DNA libraries as previously described
in [52]. ChIP DNA and input DNA were first band-
isolated on a 2% agarose to obtain fragments between
150 and 350 base pairs and DNA was extracted using the
QIAquick gel extraction kit (Qiagen) and eluted in 34 μl.
After end-repair and addition of a single adenosine ("A")
nucleotide, adapters were ligated to samples for 15 min
at room temperature in the following fashion: the sam-
ples eluted from the MinElute column in 10 μL were
ligated to 1 μl of adapters using 1.3 μL of LigaFast T4
DNA Ligase (3 Units/μl; Promega) and 12.3 μL Rapid
Ligation Buffer (Promega). For DNA libraries, the Illu-
mina genomic DNA adapters were diluted 1:10. After
15 min, samples were purified with the MinElute PCR
purification kit (Qiagen).
Adapters in excess were eliminated by using gel purifi-
cation on a 2% agarose E-Gel (Invitrogen) for 20 min, to-
gether with Track-It 50 bp DNA ladder (Invitrogen).
DNA fragments ranging from 150 base pairs to 500 base
pairs were extracted and recovered in 28 μl EB with a
QIAquick gel extraction kit (Qiagen). To amplify the li-
brary, PCR was performed using Illumina genomic DNA
primer "1.1" and Illumina genomic DNA primer "2.1"
with 15 cycles (Input DNA) or 17 cycles (ChIP DNA) of
amplification. A final size selection was performed using
a 2% agarose E-Gel to obtain a library with a median
length of ~230 bp which is within the recommended size
range for cluster generation on Illumina's flow cell. The
library was recovered in 20 μl EB using MinElute Gel
Extraction kit (Qiagen). Finally, DNA concentrations and
purities (A260/280 nm ratios) were measured on a
Nanodrop spectrophotometer. Sequencing was carried
out on the Illumina (Solexa) platform at a sequencing
depth of 1 lane averaging 10 million reads, read length of
27 + bp, single-end reads and mapped to mouse genome
build (mm9).
Establishment of list of reference loci
ChIP-seq data were mapped using the ELAND soft-
ware (Illumina) allowing one mismatch. Mapped read
data were used as an input and to establish list of loci
using MACS (Using default parameters except: mfold
12; tag size according to platform; band width 100)
[23]. Input DNA file was used as a control in all peak
detection analyses. To calculate a single enrichment
value for a binding site, tag density is defined as the
number of tags present or overlapping in user-definedwindow around the reference site. The algorithm for
the signal enrichment calculation is described in details
in [33].
Average profile calculations
We extracted the tag density in a 5 kb window sur-
rounding the TSSs and gene body using the program
seqMINER which generates heatmap as well as the pro-
files [33]. The sequenced ChIP-seq reads represent only
the end of each immunoprecipitated fragments instead
of the precise protein-DNA binding sites. To illustrate
the entire DNA fragment, basically before analysis, 30
end of each ChIP-seq read was extended to 200 bp in
the direction of the reads. For average gene profiles,
genes (+/-5000 bp from binding site) were divided in
100 bins of length relative to the gene length. Moreover
10 equally sized (50 bp) bins were created on the 5’ and
3’ of the gene and ChIP-seq densities were collected for
each dataset in each bin. The average of enrichments
over input in each bin was plotted for each dataset. For
average TSS profile, the genes as above were aligned on
their TSSs and densities were collected in 100 equally
sized bins around the TSS (-/+5000 bp).
Identification of intergenic regions
The list of refseq genes was obtained from UCSC table
browser [28]. Co-ordinates for the intergenic regions
were extracted from refseq genes using complement
intervals of a dataset tools from Galaxy web server
(https://main.g2.bx.psu.edu/). All those regions, which
do not correspond to the beforehand defined promoter
regions, that are not gene bodies, and are not regions
that are situated 2 kb downstream of the end of anno-
tated genes, are considered as intergenic regions. Over-
lapping piece of intervals (from Galaxy web tools) with
an overlap of at least 500 bps was used to distinguish
peaks, which are intergenic for H3K9 and H3K14
acetylation.
Data source
ChIP-seq datasets were downloaded from the public data
bank Gene Expression Omnibus (http://www.ncbi.nlm.
nih.gov/gds) under the accession number: GSM307618
(H3K4me3-mES); GSM307619 (H3K27me3-mES); GSM307621
(H3K9me3-mES); GSM594577 (H3K4me1-mES); GSM594578
(H3K27ac-mES); GSM307623 (Pol II-mES); GSM307624
(total H3-mES); GSM307625 (input-mES); GSM699164
(p300-mES). The sequencing data we have generated is
deposited in the GEO database under the accession
number GSM775313 (H3K9ac-mES) and GSM775314
(H3K14ac-13HH3-1A5-mES). CpG island definition and
locations of known genes were downloaded from UCSC
genome browser [28]. Number of mapped reads for each
data set is provided in the Additional file 9: Table S2.
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http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
token=nhclxooaewkmqvq&acc=GSE31284.
Creation of density files for genome browser data
visualization
Raw BED files are used as input for ad hoc (WIG) dens-
ity file creation script as described in [33]. Reads are dir-
ectionally extended of their theoretical length (200 bp),
and 25 bp bins are created. In each bin, the maximal
number of overlapping reads is computed. Tracks were
uploaded and displayed using fixed scale representation
in the UCSC genome browser [28].
Data analysis
The scatter plots, k-means clustering and average gene
profiles are created using seqMiner [33]. Box plots and
correlation analysis are produced using R software
(http://r-project.org/). The distribution of H3K9ac and
H3K14ac in various genomic regions is calculated using
the CEAS software [22]. Briefly, CEAS estimates the
relative enrichment level of ChIP regions in each gene
feature with respect to the whole genome. In our ana-
lysis promoters correspond to the 2 kb upstream regions
from the transcription start site (TSS) of refseq genes.
All those regions, which do not correspond to the be-
forehand defined promoter regions, that are not gene
bodies, and are not regions that are situated 2 kb down-
stream of the end of annotated genes, are considered as
intergenic regions (more details are available at http://
liulab.dfci.harvard.edu/CEAS/usermanual.html and [22]).
Gene ontology was performed using David Bioinformat-
ics tools (http://david.abcc.ncifcrf.gov/home.jsp).
Additional files
Additional file 1: Figure S1. The commercially available anti-H3K14ac
antibody (Upstate (07-353)) cross-reacts with other peptides. Enzyme
linked immunosorbent assay (ELISA) using various peptides such as
H3K14 acetylated (H3K14ac) and non-acetylated (H3K14) and non specific
histone H4 acetylated peptide (H4K5ac-K12ac) suggest that anti-H3K14ac
antibody from Upstate (07-353) cross-reacts with non-acetylated H3K14
peptide as well as with H4K5andK12ac peptide.
Additional file 2: Figure S2. Characterization of mouse monoclonal
anti-H3K14ac (13HH3-1A5) antibody. (A) Western blot analysis using the
13HH3-1A5 (anti H3K14ac antibody) on the recombinant E. coli expressed
histone H3 and histones extracted by and acidic extraction protocol from
human HeLa cells (right panel). Coomassie blue stained SDS-PAGE of the
proteins used for the western blot analysis in a 100-fold dilution.
(B) Enzyme linked immunosorbent assay (ELISA) using various peptides
such as H3K14 acetylated (H3K14ac) and non-acetylated (H3K14), H3K14
dimethylated, H3S10 phosporylated and K14 dimethylated
(H3pS10K14dimethyl), H3S10 phosporylated (H3pS10), H3K9 dimethylated
(H3K9dimethyl), H3S10 phosporylated and K9 dimethylated
(H3pS10K9dimethyl) and histone H4 acetylated peptide (H4K5, 8, 12
and 16 ac).
Additional file 3: Figure S3. Validation of (A) H3K9ac and (B) H3K14ac
ChIP-seq in mouse embryonic stem cells by ChIP-qPCR. Peaks of localenrichment of H3K9 and H3K14 acetylation were determined after
sequence alignment and normalization to input DNA. Tag density per
peak (shown on the right of the graph) is plotted as fold enrichment
over an arbitrarily chosen control genomic region. The list of primer is
provided as Supplementary Table S1. These ChIP-qPCR results confirmed
the specificity of the predicted peaks for H3K9 and H3K14 acetylation.
Additional file 4: Table S1. List of primers used for ChIP-qPCR
validation.
Additional file 5: Figure S4. Enrichment of H3K9ac and H3K14ac over
various genomic regions. Average enrichment profile of H3K9 and
H3K14ac over the promoters, coding exons, introns and distal intergenic
regions. Enrichment over distal intergenic and intronic sites is
comparable to promoters.
Additional file 6: Figure S5. Correlation of H3K9ac (A) and H3K14ac (B)
intergenic peaks with H3K4me1, H3K27ac, Pol II and p300. Heatmaps of
the signal density using k-means clustering over H3K9ac and H3K14ac
distal intergenic sites (-/+ 5 kb). Strong correlation with H3K4me1 and
H3K27ac and presence of Pol II and p300 over H3K9ac and H3K14ac
intergenic sites suggest that they may act as enhancers.
Additional file 7: Figure S6. Measurement of Oct4 level at various time
points after the treatment with 5 mg/ml sodium butyrate in ES cells.
Level of Oct4 was monitored by Western blot to see the pluripotent state
of the ES cells at various time points after sodium butyrate treatment.
The similar levels of Oct4 observed at different experimental time points
suggest that the time points we have used for sodium butyrate
treatment have no effect on pluripotency of the ES cells. Tubulin was
used as a loading control.
Additional file 8: Figure S7. Ratio of tag density of least expressed to
highest expressed gene promoters for H3K9 and H3K14 acetylation. H3K9
and H3K14 acetylation tag density were calculated over 500 least and
highest expressed gene promoters based upon their RNA-sequencing
expression profile. The ratio of tag density of least expressed to highest
expressed plotted for H3K9 and H3K14 acetylation, which shows that
H3K14ac is specifically enriched at inactive promoters as compared to
H3K9ac.
Additional file 9: Table S2. Number of mapped reads for the data set
used in this study.
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